| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,794 | 22,602 | 13,845 | 929 | | Cost of Revenue | 16,374 | 15,394 | 9,498 | 1,782 | | | Gross Profit | 7,419 | 7,207 | 4,346 | (853) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,373 | 2,740 | 2,009 | 5,247 | | Non Recurring |
-
| (40) | 40 |
-
| | Others |
-
|
-
|
-
| (692) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,953) | 4,507 | 2,298 | (5,408) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 12,768 | (13,059) | 291 | 1,648 | | Earnings Before Interest And Taxes | 8,815 | (8,552) | 2,589 | (3,760) | | Interest Expense | (160) | 743 | 620 | 579 | | Income Before Tax | 8,975 | (9,295) | 1,969 | (4,339) | | Income Tax Expense | (3,653) | 1,348 | 714 | (10,491) | | Minority Interest | 86 | 146 | 47 | 160 | | | | Net Income From Continuing Ops | 12,714 | (10,497) | 1,303 | 6,312 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,714 | (10,497) | 1,303 | 6,312 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,714 | ($10,497) | $1,303 | $6,312 |
|
0.17% Nasdaq 
Income Statement
